-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The term "Quality of Life" (QoL) was proposed by the British economist Arthur Cecil Pigou in a 1920 publication, and was later fully implemented as an important concept in philosophy and politics
Parkinson's disease (PD) is one of the most common neurodegenerative diseases, and it is an extremely heavy burden for patients, families and caregivers
Maintaining and improving patients' QoL is one of the main goals of care for patients with chronic diseases
So far, the management of PD is mainly through medication and physical therapy to improve symptoms, and the success of treatment is mainly evaluated by evaluating QoL
However, objective living conditions can be assessed differently on a subjective level according to their personal meaning to life>
However, in recent years, there have been more and more scientific efforts to consider QoL from a holistic perspective, which has been applied to various patient groups
In this way, Franziska Thiekena and others of the University Hospital of Marburg in Germany developed a digital framework for longitudinal assessment of the quality of life during the progression of Parkinson's disease
Wagner and others established the CHAPO model (challenges and potentials) in a huge study to assess the quality of life of the elderly
They found that the development of the CHAPO-PD model has been completed, and it is the first major result of this research
The important aspects of QoL and the way in which QoL is determined are based on the statements of PD patients, caregivers, and health professionals
Compared with the questionnaires used so far, CHAPO-PD not only considers the loss of QoL due to the severity of symptoms, but also provides an assessment of patients' satisfaction with motor function and treatment effects
In addition, within the scope of QoL assessment, resilience (defined as PD's response and positive factors) can be assessed for the first time
By considering the overall understanding of the quality of life, it is found that previously unrecognized factors are related to the subjective well-being of patients with Parkinson's disease, or these findings can be used to improve the structure of healthcare for patients with Parkinson's disease and related diseases
It is found that factors that have not been recognized before are related to the subjective well-being of patients with Parkinson's disease, or these findings can be used to improve the structure of healthcare for patients with Parkinson's disease and related diseases
Leave a message here
